Citizens Maintains AMERISAFE at Market Outperform, Cuts Target to $35
Citizens kept its Market Outperform rating on AMERISAFE and lowered its price target to $35 from $40.
Citizens kept its Market Outperform rating on AMERISAFE and lowered its price target to $35 from $40.